• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

DDI Webinar - Medwatch - January 29, 2013

The Food and Drug Administration, Center for Drug Evaluation and Research (CDER), is delighted to inform you of a unique opportunity for healthcare professionals, pharmacy students, nurse practitioner students and medical students in the United States to learn more about the FDA and drug regulation. CDER's Division of Drug Information (DDI) is offering a series of educational webinars, developed by FDA pharmacists and targeted to the needs of all healthcare professionals and students.

 
These focused webinars support FDA's mission of promoting and protecting public health, through interaction and education to strengthen relationships with future clinicians, researchers, nurses, and pharmacists. Fostering this connection will provide a better understanding of FDA's role in public health as a regulatory agency.
 
On January 29, 2013, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled, “Introduction to FDA's MedWatch Adverse Reporting Program”. The featured speaker, Anna M. Fine Pharm.D., MS, Director, Health Professional Liaison Program in FDA’s Office of Special Health Issues gave an overview of the program,  how to report adverse events to FDA MedWatch, and where to find clinically relevant information from MedWatch.
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.